Vanda Pharmaceuticals (VNDA) Return on Sales [ROS] (2009 - 2026)
Vanda Pharmaceuticals (VNDA) posted Return on Sales [ROS] of -126.28% for Q2 2026, down 53.07 percentage points from -73.21% a year earlier and down 29.17 percentage points from the prior quarter.
Vanda Pharmaceuticals (VNDA) Return on Sales [ROS] (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at Vanda Pharmaceuticals was -86.07%, down 36.52 percentage points year-over-year; for FY2025, it came in at -69.95%, down 49.50 percentage points from FY2024.
- Annual Return on Sales [ROS] has declined for four consecutive years, with a five-year change of -80.93 percentage points (FY2020 to FY2025).
- In prior years, Vanda Pharmaceuticals' Return on Sales [ROS] was -20.46% in FY2024 (-13.21 pp), -7.24% in FY2023 (-9.73 pp), 2.49% in FY2022 (-13.21 pp) and 15.69% in FY2021 (+4.72 pp).
- The Q2 2026 figure stands as the lowest quarterly Return on Sales [ROS] since Q2 2014.
- On a year-over-year basis, Return on Sales [ROS] has declined in each of the last 13 quarters, with an average year-over-year change of -34.86 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q1 2023, with a gain of 15.95 percentage points; the weakest was Q1 2025, with a drop of 62.53 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -97.11% (Q1 2026), -70.53% (Q4 2025) and -55.61% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Vanda Pharmaceuticals | 246.71 Mn | -529.97 Mn | 65.66 Mn | -33.69% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -33.69% |
| Jun 30, 2026 | -126.28% |
| Mar 31, 2026 | -97.11% |
| Dec 31, 2025 | -70.53% |
| Sep 30, 2025 | -55.61% |
| Jun 30, 2025 | -73.21% |
| Mar 31, 2025 | -81.99% |
| Dec 31, 2024 | -19.33% |
| Sep 30, 2024 | -23.08% |
| Jun 30, 2024 | -20.10% |
| Mar 31, 2024 | -19.46% |
| Dec 31, 2023 | -15.67% |
| Sep 30, 2023 | -15.45% |
| Jun 30, 2023 | -6.23% |
| Mar 31, 2023 | 3.21% |
| Dec 31, 2022 | 10.28% |
| Sep 30, 2022 | 5.98% |
| Jun 30, 2022 | 5.38% |
| Mar 31, 2022 | -12.74% |
| Dec 31, 2021 | 12.70% |
Vanda Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VNDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();